Picture of Tempus AI logo

TEM Tempus AI News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Brief: Renalytix Announces Collaboration With Tempus To Advance Intelligent Risk Assessment In Diabetic Kidney Disease

Sept 15 (Reuters) - Renalytix PLC RENX.L:

RENALYTIX ANNOUNCES COLLABORATION WITH TEMPUS TO ADVANCE INTELLIGENT RISK ASSESSMENT IN DIABETIC KIDNEY DISEASE

Source text: ID:nPnbSn716a

Further company coverage: RENX.L

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tempus AI

See all news